Advertisement
Screener

MOBIA MEDICAL, INC. (MOBI) Current Ratio

MOBIA MEDICAL, INC. (MOBI) Current Ratio

  • Current ratio · latest quarter: Value 13.28×; Formula and calculation Current assets / current liabilities..

Current ratio

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Current ratio · latest quarter13.28×Current assets / current liabilities.

$192.15M ÷ $14.47M ≈ 13.28×

Calculation inputs

InputAmount with unitRaw financial data
Current assets192.15M USDAssets, Current
Current obligations14.47M USDLiabilities, Current
Cash and equivalents177.09M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables5.66M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory6.95M USDInventory, Net
Payables2.36M USDAccounts Payable, Current
Borrowing debt due within one year(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCurrent assets (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory (USD)Payables (USD)Borrowing debt due within one year (USD)Current ratio
2026-06-30$192.15M$14.47M$177.09M(m)$5.66M$6.95M$2.36M(m)13.28×
2026-03-31$71.71M$11.83M$55.73M(m)$4.85M$6.05M$3.03M(m)6.06×
2025-12-31$46.36M$10.21M$33.59M(m)$4.43M$5.46M$2.22M(m)4.54×

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
Embecta Corp. (EMBC)United States$0.319B2.10
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B